Tcell

Tcell company information, Employees & Contact Information

Explore related pages

Related company profiles:

Tcell is one of the biggest telecommunication companies in Tajikistan, the sole owner of which is the Aga Khan Fund for Economic Development (AKFED). AKFED is an international development agency dedicated to promoting entrepreneurship and building economically sound enterprises in the developing world. AKFED is one of the agencies in the AKDN system – the network of private, organizations that work to improve the welfare and prospects of people in the developing world. AKDN aims to improve living conditions and opportunities for people regardless of their particular religion, race, ethnicity, or gender. AKDN works towards the vision of an economically dynamic, politically stable, intellectually vibrant, and culturally tolerant Tajikistan.

Company Details

Employees
376
Address
Rudaki 34, Dushanbe,dushanbe 734025,tajikistan
Industry
Telecommunications
NAICS
Telecommunications
Other Telecommunications
Telecommunications Resellers
All Other Telecommunications
Website
tcell.tj
Keywords
Babilon-T LLC.
HQ
Dushanbe, Dushanbe
Looking for a particular Tcell employee's phone or email?

Tcell Questions

News

Inhibition of ENT1 relieves intracellular adenosine-mediated T cell suppression in cancer - Nature

Inhibition of ENT1 relieves intracellular adenosine-mediated T cell suppression in cancer Nature

CAR-T cell therapy in Multiple Myeloma: current status and future challenges - Nature

CAR-T cell therapy in Multiple Myeloma: current status and future challenges Nature

CAR T-Cell therapy for the management of mantle cell lymphoma - Molecular Cancer

CAR T-Cell therapy for the management of mantle cell lymphoma Molecular Cancer

Universal antigen encoding of T cell activation from high-dimensional cytokine dynamics - Science | AAAS

Universal antigen encoding of T cell activation from high-dimensional cytokine dynamics Science | AAAS

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study - The Lancet

CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study The Lancet

Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer - Science | AAAS

Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer Science | AAAS

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection - Nature

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection Nature

Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy - Nature

Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy Nature

Mechanisms of resistance to CAR T cell therapy - Nature

Mechanisms of resistance to CAR T cell therapy Nature

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell - Nature

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell Nature

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling - Nature

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling Nature

Top Tcell Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant